Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Covidien to expand sales force thanks to FDA drug approval
Bizjournals.com
Tuesday, March 2, 2010 - 11:10am
tags:
hirings, sales force, Covidien, FDA, Exalgo
Covidien, CombinatoRx painkiller Exalgo gets FDA nod
Reuters
Tuesday, March 2, 2010 - 11:06am
tags:
Covidien, CombinatoRx, Exalgo, painkillers, FDA
Are activist shareholders poison for biotech?
Fierce Pharma
Tuesday, March 2, 2010 - 11:05am
tags:
Carl Icahn
Pluristem Therapeutics, Compugen, Antares: Early Volume Plays
TheStreet.com
Tuesday, March 2, 2010 - 11:02am
tags:
Pluristem, CompuGen, Antares
Sequenom, CombinatorRx lead drug stocks north
Marketwatch
Tuesday, March 2, 2010 - 11:00am
tags:
Sequenom, drug stocks, CombinatoRx
Report Claims Dendreon Facing FDA Panel
TheStreet.com
Tuesday, March 2, 2010 - 10:56am
tags:
Dendreon, FDA, Provenge
Three Undervalued Cancer Drug Makers
Seeking Alpha
Tuesday, March 2, 2010 - 10:53am
tags:
cancer, Ariad Pharmaceuticals, Spectrum Pharmaceuticals, Delcath
Will OSI offer touch off a bidding war?
Fierce Pharma
Tuesday, March 2, 2010 - 10:51am
tags:
Astellas, OSI Pharmaceuticals, M&A, Roche
Specialty Drugs, Medicare D & Catastrophic Coverage
Pharmalot
Tuesday, March 2, 2010 - 10:50am
tags:
Medicare
Allos Extends Losses
Yahoo/Zacks.com
Tuesday, March 2, 2010 - 10:48am
tags:
Allos, earnings
Impax gets FDA OK for prostate drug
Bizjournals.com
Tuesday, March 2, 2010 - 10:47am
tags:
Impax, FDA, Flomax
AstraZeneca Chief Talks Pharma Challenges
Businessweek
Tuesday, March 2, 2010 - 10:46am
tags:
David Brennan, AstraZeneca, Pharma CEOs
Hedge Funds Heart Pfizer
NY Times, NY
Tuesday, March 2, 2010 - 10:45am
tags:
hedge funds, Pfizer
Connecticut AG Urges Curbs On Pharma Influence
Pharmalot
Tuesday, March 2, 2010 - 10:44am
tags:
Connecticut, physician gifts
Bayer's Birth-Control Problem Is Exploding: 1,100 Lawsuits Allege Yaz Causes Blood Clots
BNET Pharma
Tuesday, March 2, 2010 - 9:02am
tags:
Bayer, birth control pill, Yaz
Anthera IPO: Second Biotech to Price Low, but Price Isn't Everything
BNET Pharma
Tuesday, March 2, 2010 - 9:00am
tags:
IPOs, Anthera
Bristol-Myers: FDA panel clears a transplant drug Bristol-Myers: FDA panel clears a transplant drug
Marketwatch
Tuesday, March 2, 2010 - 8:47am
tags:
Bristol-Myers Squibb, FDA, transplant drugs, belatacept
Summary Box: Merck pays last $4.1B for Vioxx patient settlements, some other suits continue
Yahoo/AP
Tuesday, March 2, 2010 - 7:27am
tags:
Merck, Vioxx, settlements
UCB Drops After Forecasting 2010 Earnings Won’t Rise
Bloomberg
Tuesday, March 2, 2010 - 7:25am
tags:
UCB Pharmaceuticals, guidance, earnings
Astellas Sues OSI for Rejecting $3.5 Billion Offer
Bloomberg
Tuesday, March 2, 2010 - 7:24am
tags:
Astellas, lawsuits, M&A, OSI Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.